Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Effects of Antioxidants and Pro-oxidants on Cytotoxicity of Dihydroartemisinin to Molt-4 Human Leukemia Cells

THOMAS GERHARDT, ROSS JONES, JUNGSOO PARK, RUI LU, HO WING CHAN, QINGXI FANG, NARENDRA SINGH and HENRY LAI
Anticancer Research April 2015, 35 (4) 1867-1871;
THOMAS GERHARDT
Department of Bioengineering, University of Washington, Seattle, WA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROSS JONES
Department of Bioengineering, University of Washington, Seattle, WA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUNGSOO PARK
Department of Bioengineering, University of Washington, Seattle, WA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RUI LU
Department of Bioengineering, University of Washington, Seattle, WA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HO WING CHAN
Department of Bioengineering, University of Washington, Seattle, WA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
QINGXI FANG
Department of Bioengineering, University of Washington, Seattle, WA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NARENDRA SINGH
Department of Bioengineering, University of Washington, Seattle, WA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: narendra@u.washington.edu
HENRY LAI
Department of Bioengineering, University of Washington, Seattle, WA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: The objective of the present study was to investigate how oxidative status influences the effective ness of cytotoxicity of artemisinin towards cancer cells. It is hypothesized that antioxidants would reduce, whereas pro-oxidants would enhance, cytotoxicity. Materials and Methods: Molt-4 human leukemia cells were incubated with vitamins C, E, D3, dexamethasone, or hydrogen peroxide alone or in combination with dihydroartemisinin (DHA). Concentrations of these compounds studied were similar to those achievable by oral administration. Viable cell counts were performed before (0 h) and at, 24 and 48 h after treatment. Results: Vitamin C, vitamin D3, dexamethasone, and H2O2 caused significant Molt-4 cell death. Vitamin E caused an increase in Molt-4 cell growth. Vitamin C and vitamin D3 significantly interacted with DHA at the 48-h time point and with H2O2 at both 24-h and 48-h time points. Conclusion: Cellular oxidative status could alter the potency of artemisinin in killing cancer cells.

  • Artemisinin
  • sodium ascorbate
  • vitamin D3
  • Trolox
  • dexamethasone
  • hydrogen peroxide
  • Molt-4 cells

Environmental factors, such as nutrition and nutritional supplementation, can explain some of the variability seen among treatment outcomes of cancer patients (1). To explore this possibility, we tested the effects of several nutritional supplements commonly taken by cancer patients on an experimental cancer drug artemisinin, which we have been investigating as an alternative to current chemotherapeutics (2). Artemisinin, a compound isolated from the plant Artemisia annua L (sweet wormwood), and its derivatives are currently the most effective anti-malarials (3). Artemisinin compounds have also been shown to be potent and selective anticancer agents both in vitro and in vivo (2). Artemisinin's anticancer mechanism has been hypothesized to arise from the interaction of its endoperoxide moiety with free ferrous iron, which is more abundant in cancer cells, generating cytotoxic reactive oxygen species (ROS) (4, 5). There are several case reports of cancer treatment using artemisinin (6-8).

In the present study, we investigated whether various nutritional supplements interact with the more hydrophilic artemisinin analog dihydroartemisinin (DHA) in killing cancer cells. Since artemisinin works by overloading cancer cells with ROS, we selected molecules that are known to affect the oxidative status of cells. For their antioxidant properties, we studied sodium ascorbate (vitamin C) and Trolox (vitamin E). For their pro-oxidant properties, in certain cancer cells, we studied vitamin D3, dexamethasone (dexamethasone 21-acetate), and hydrogen peroxide (H2O2). To evaluate the interactions of artemisinin with these agents, we used the commonly studied, rapidly growing and easily cultured Molt-4 human lymphoblastic leukemia cells.

Materials and Methods

Chemicals. All chemicals were purchased from Sigma Aldrich (St. Louis, MO, USA) unless mentioned otherwise.

Molt-4 cell culture. Molt-4 cells were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). They were cultured in RPMI-1640 media (Life Technologies, Grand Island, NY, USA) with 10% fetal bovine serum (ATCC) at 37°C with 5% CO2 and 100% humidity to reach a density of 6×105 cells/ml before diluting to a density of 6×104 cells/ml approximately 24 h prior to a treatment. Twenty-four hours of pre-incubation allowed the cells and media to be conditioned prior to exposure to supplements and experiments to begin at a density of approximately 1×105 cells/ml. At this time, cells were in the log phase. Viable cells were counted before drug treatment (0 h) and at 24 h and 48 h after treatment using a hemocytometer. To assess cell viability, we used trypan blue exclusion and identified dead cells based upon morphological criteria: chromatin condensation, formation of apoptotic bodies, shrinkage of the cytoplasm, and blebbing of the plasma membrane with irregular outline (9, 10). Only healthy cells were counted.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Results of two-way ANOVA showing significant differences of dihydroartemisinin (DHA), supplements (ascorbate, Vitamin D3, dexamethasone, Trolox and hydrogen peroxide) and interaction (DHA+supplements) effects at the 24-h and 48-h time points. Results showing significance are in bold.

Cell treatment. There were four treatment groups: control (no-drug treatment), Dihydroartemisinin (DHA) alone, supplement alone, and DHA+supplement. DHA (Holley Pharmaceuticals, Chongqing, China) was used at a concentration of 12.4 μM. This concentration was used because it is similar to the maximum blood concentration in rats after an oral dosage of 10 mg/kg (11). It was also the concentration used in our previous studies. The supplement samples were added with the following concentrations: ascorbate 256 μM, vitamin D3 75 nM, Trolox 45.8 μM, dexamethasone 21-acetate 10 μM, and H2O2 8.82 μM, according to standard achievable in vivo concentrations of these compounds. Dimethyl sulfoxide (DMSO) was the solvent for DHA, dexamethasone, Trolox, and vitamin D3. All other compounds were dissolved in RPMI-1640 media. All groups were controlled at 1% DMSO by adding the appropriate amount of DMSO directly to the suspension culture at the experimental initiation. Each experiment was performed at least three times.

Data analysis. Data were expressed as the ratio of cell counts at the 24-h or 48-h time point relative to time zero. The GraphPad Prism 6.03 software (La Jolla, CA, USA) was used for statistical analysis. A two-way ANOVA was performed to test for significances of main effects of DHA and supplements, as well as their interaction effect. Pair-wise comparisons were analyzed using the Newman Keul's test. A p<0.05 was considered statistically significant.

Results

Data of effects of DHA and different supplements on Molt-4 cells are presented in Figure 1. Results of two-way ANOVA showing significances of main and interaction effects are presented in Table I.

In all cases, DHA-alone significantly decreased cell counts relative to untreated cells at both 24-h and 48-h time points. All supplements studied also affected cell counts. Compared to control, ascorbate and H2O2 both caused a significant decrease in cell count both at 24-h (p<0.05 and p<0.0001 for ascorbate and H2O2, respectively) and 48-h (p<0.0001 for both ascorbate and H2O2) time points. Dexamethasone and vitamin D3 caused a significant decrease in cell count only at the 48-h time point (p<0.01 for both supplements). A significant increase in cell count was observed at the 24-h time point for Trolox (p<0.05). Thus, all supplements, except for Trolox, caused a decrease in cell counts.

Hydrogen peroxide in combination with DHA caused significantly greater cell death than DHA-alone at both time points (p<0.01 and p<0.05 for 24-h and 48-h time points, respectively). Also, the effect of dexamethasone combined with DHA was found to be significantly greater than DHA alone at the 48-h time point (p<0.05). However, cell counts of ascorbate, vitamin D3 or Trolox in combination with DHA are not significantly different from DHA alone at both 24-h and 48-h time points. This is reflected in the results of the two-way ANOVA (Table I) indicating that H2O2 significantly interacted with DHA at both time points, whereas ascorbate and Vitamin D3 were found to interact at the 48-h time point. No significant interaction effect was observed between DHA and Trolox or dexamethasone.

Discussion

The effectiveness of artemisinin may be due to its free radical generation capabilities in the presence of Fe2+ causing widespread effects on cancer cells (12, 13). If patients are undergoing cancer therapies with drugs like artemisinin, which rely on oxidative stress, then it is important to know how supplementation with oxidative-state modulating compounds will affect the therapy. It may be possible to improve therapeutic outcomes by compounding the oxidizing effect of artemisinin and certain supplements, pushing cancer cells toward oxidative overload (14).

Vitamin C, a common supplement, has been shown to act as both a ROS generator in the presence of iron and copper (15) and as an antioxidant (16). The normal blood concentration of vitamin C is approximately 64 μM in an adult man (17). We hypothesize that ascorbate acts more like a pro-oxidant in cancer cells due to their higher cytoplasmic iron levels. From our results, we can postulate that ROS generation is causing cell death independently and in combination with DHA. Variation in cancer therapy out comes with drugs targeting oxidative stress may be caused, in part, by vitamin C levels, since it is a commonly used supplement.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Effects of dihydroartemisinin (DHA), supplements, and DHA+supplements on Molt-4 cells at 24-h and 48-h time points. Error bar denotes standard deviation. *: p<0.05, **: p<0.01, ****: p<0.0001 comparing supplement with control. †: p<0.05, ††: p<0.01 comparing DHA+ supplement with DHA.

However, one must be careful in taking vitamin C in combination with DHA. Ascorbate can convert ferric iron into ferrous iron (18), the active form that reacts with artemisinin, generating short lived free radicals. If this happens in the stomach of a person who is consuming artemisinin along with ascorbate, ascorbate will convert ferric iron in foods to the ferrous form, which may react with artemisinin locally, making the therapy less effective. To avoid this issue, ascorbate may be administered intravenously or taken orally at a different time of day as artemisinin.

Vitamin D3 has been shown to act as a pro-oxidant and an antioxidant in malignant and non-malignant human prostate epithelial cells, respectively (19).Vitamin D3 concentrations range between 75 and 190 nM in the blood (20), varying with an individual's age, sunlight exposure, race and other supplement intake (21). Our results indicate that vitamin D3 reduces leukemia cell growth independently but has no significant interaction effect with DHA. The reason of the lack of an interaction effect is unknown. Perhaps, vitamin D3 becomes an antioxidant in cancer cells at longer time points. It may be of interest to study the interaction of vitamin D3 levels with artemisinin in vivo, as vitamin D3 is involved in regulation of calcium and phosphorus intake (22), immune function (23) and, thus, may be involved in more complex interactions with DHA in cancer cells.

The normal blood concentration of vitamin E is 22.9 μM, with a range of 12 to 59 μM (25). Our results with the water-soluble vitamin E analog, Trolox, alone show an increase in leukemia cell growth at the 24-h time point, with no significant interaction with DHA. Vitamin E has been shown to decrease the anti-angiogenic effects of artemisinin (26); thus, it is pertinent to study how it interacts with DHA in vivo, where angiogenesis is a major factor in tumor growth.

Dexamethasone is shown to induce oxidative stress-mediated apoptosis in lymphoid tissue (27). Our results demonstrate that dexamethasone reduces leukemia cell growth. There was no significant interaction with DHA. Due to the anti-inflammatory nature of dexamethasone, it will be important to further study its interaction with DHA in vivo, where inflammation is a key factor in tumor modulation by the immune system.

H2O2 is a known signaling molecule and strong oxidizing agent. Normal human plasma concentration of H2O2 is approximately 11.1 μM (31) and can be increased with exercise (32). Our H2O2 results indicate that H2O2 kills leukemia cells alone. Furthermore, the interaction between H2O2 and DHA was found to be additive, which may be due to the similar methods of apoptosis mediation by ROS generation employed by both compounds.

We have explored the interaction effects of several nutritional supplements and natural compounds with antioxidant and pro-oxidant properties with DHA on Molt-4 cells. Some of these compounds could increase or decrease the anticancer effectiveness of artemisinin in vitro. We do not yet know the therapeutic values of our in vitro findings; however, implications of this work could pave the way for setting new treatment regiments for patients undergoing artemisinin therapy for cancer. Our goal is to understand variability between patients and, hopefully, use this knowledge to reduce the easily achievable dosage of artemisinin required for successful cancer treatment. Our strategy presents an attractive option for patients who are looking to optimize their treatments through nutritional modulation. Future in vivo research is needed to confirm our findings in animals and humans and to study more complex systemic interactions with the supplement molecules.

Footnotes

  • Conflicts of Interest

    The Authors declare no conflicts of interest with respect to this study.

  • Funding

    Funding for this research was provided in part by the Dean of the College of Engineering and Associate Vice Provost for Research of the University of Washington and the Washington State Life Science Discovery Fund (LSDF).

  • Received December 15, 2014.
  • Revision received January 14, 2015.
  • Accepted January 16, 2015.
  • Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Lagiou P,
    2. Trichopoulou A,
    3. Trichopoulos D
    : Nutritional epidemiology of cancer: accomplishments and prospects. Proc Nutr Soc 61: 217-222, 2002.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Lai HC,
    2. Singh NP,
    3. Sasaki T
    : Development of artemisinin compounds for cancer treatment. Invest New Drugs 31: 230-246, 2013.
    OpenUrlCrossRefPubMed
  3. ↵
    1. White NJ
    : Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41: 1413-1422, 1997.
    OpenUrlFREE Full Text
  4. ↵
    1. Lai HC,
    2. Singh NP
    : Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 91: 41-46, 1995.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Singh NP,
    2. Lai HC
    : Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 70: 49-56, 2001.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Singh NP,
    2. Verma KB
    . Case report of a laryngeal squamous cell carcinoma treated with artesunate. Arch Onc 10: 279-280, 2002.
    OpenUrl
    1. Singh NP,
    2. Panwar VK
    . Case report of a pituitary macroadenoma treated with artemether. Integr Cancer Ther 5: 391-394, 2006.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Berger TG,
    2. Dieckmann D,
    3. Efferth T,
    4. Schultz ES,
    5. Funk JO,
    6. Baur A,
    7. Schuler G
    : Artesunate in the treatment of metastatic uveal melanoma--first experiences. Oncol Rep 14: 1599-1603, 2005.
    OpenUrlPubMed
  8. ↵
    1. Searle J,
    2. Kerr JFR,
    3. Bishop CJ
    : Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Ann 17: 229-259, 1982.
    OpenUrlPubMed
  9. ↵
    1. Kerr JFR,
    2. Wyllie AH,
    3. Currie AR
    : Apoptosis: a Basic biological phenomenon with wide-ranging applications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Li QG,
    2. Peggins JO,
    3. Fleckenstein LL,
    4. Masonic K,
    5. Heiffer MH,
    6. Brewer TG
    : The pharmacokinetics and bioavailability of dihydroartemisinin, artether, artemether, artesunic acid and artelinic acid in rats. J Pharm Pharmacol 50: 173-182, 1998.
    OpenUrlPubMed
  11. ↵
    1. O'Neill PM,
    2. Barton VE,
    3. Ward SA
    : The molecular mechanism of action of artemisinin--the debate continues. Molecules 15: 1705-1721, 2010.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Chan HW,
    2. Singh NP,
    3. Lai HC
    . Cytotoxicity of dihydroartemisinin toward Molt-4 cells attenuated by N-tert-butyl-alpha-phenylnitrone and deferoxamine. Anticancer Res 33: 4389-4393, 2013.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Schumacker PT
    : Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10: 175-176, 2006.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Buettner GR,
    2. Jurkiewicz BA
    : Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat Res 145: 532-541, 1996.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Gao P,
    2. Zhang H,
    3. Dinavahi R,
    4. Li F,
    5. Xiang Y,
    6. Raman V,
    7. Bhujwalla ZM,
    8. Felsher DW,
    9. Cheng L,
    10. Pevsner J,
    11. Lee LA,
    12. Semenza GL,
    13. Dang CV
    :HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 12: 230-238, 2007.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Paszkowski T,
    2. Clarke R
    : The Graafian follicle is a site of L-ascorbate accumulation. J Assist Reprod Genet 16: 41-45, 1999.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Sharp P,
    2. Srai SK
    : Molecular mechanisms involved in intestinal iron absorption. World J Gastroenterol 13: 4716-4724, 2007.
    OpenUrlPubMed
  18. ↵
    1. Bao BY,
    2. Ting HJ,
    3. Hsu JW,
    4. Lee YF
    : Protective role of 1 alpha, 25-dihydroxyvitamin D3 against oxidative stress in non-malignant human prostate epithelial cells. Int J Cancer 122: 2699-2706.
  19. ↵
    1. National Library of Medicine
    . 25-hydroxy vitamin D test. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/003569.htm. Accessibility verified October 29, 2013.
  20. ↵
    1. Weng FL,
    2. Shults J,
    3. Leonard MB,
    4. Stallings VA,
    5. Zemel BS
    : Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am J Clin Nutr 86: 150-158, 2007.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Holick MF
    : Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80: 1678S-1688S, 2004.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Bikle DD
    : Vitamin D regulation of immune function. Vitam Horm 86: 1-21, 2011.
    OpenUrlCrossRefPubMed
    1. Garcion E,
    2. Wion-Barbot N,
    3. Montero-Menei CN,
    4. Berger F,
    5. Wion D
    : New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13: 100-105, 2002
    OpenUrlCrossRefPubMed
  23. ↵
    1. Goraca A
    : Assessment of total antioxidant capacity in human plasma. Folia Medica 46: 16-21, 2004.
    OpenUrlPubMed
  24. ↵
    1. Wartenberg M,
    2. Wolf S,
    3. Budde P,
    4. Grünheck F,
    5. Acker H,
    6. Hescheler J,
    7. Wartenberg G,
    8. Sauer H
    : The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies. Lab Invest 83: 1647-1655, 2003.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Baker AF,
    2. Briehl MM,
    3. Dorr R,
    4. Powis G
    : Decreased antioxidant defense and increased oxidant stress during dexamethasone-induced apoptosis: bcl-2 prevents the loss of antioxidant enzyme activity. Cell Death Differ 3: 207-213, 1996.
    OpenUrlPubMed
    1. Enoiu M,
    2. Aberkane H,
    3. Salazar JF,
    4. Leroy P,
    5. Groffen J,
    6. Siest G,
    7. Wellman M
    : Evidence for the pro-oxidant effect of gamma-glutamyltranspeptidase-related enzyme. Free Radic Biol Med 29: 825-833, 2000.
    OpenUrlCrossRefPubMed
    1. Meshnick SR,
    2. Thomas A,
    3. Ran A,
    4. Xy CM,
    5. Pan HZ
    : Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Mol Biochem Parasitol 49: 181-189, 1991.
    OpenUrlCrossRefPubMed
    1. Michaelis M,
    2. Kleinschmidt MC,
    3. Barth S,
    4. Rothweiler F,
    5. Geiler J,
    6. Breitling R,
    7. Mayer B,
    8. Deubzer H,
    9. Witt O,
    10. Kreuter J,
    11. Doerr HW,
    12. Cinatl J,
    13. Cinatl J Jr..
    : Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochem Pharma 79: 130-136, 2010.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Russell IJ,
    2. Xiao Y,
    3. Haynes WL,
    4. Michalek JE
    : Serum hydrogen peroxide levels are elevated in fibromyalgia syndrome [abstract]. Arthritis Rheum 60: Suppl 10:92, 2009.
    OpenUrl
  27. ↵
    1. Deskur E,
    2. Przywarska I,
    3. Szcześniak L,
    4. Rychlewski T,
    5. Wilk M,
    6. Wysocki H
    : Exercise-induced increase in hydrogen peroxide plasma levels is diminished by endurance training after myocardial infarction. Int J Cardiol 67: 219-224, 1998.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 35 (4)
Anticancer Research
Vol. 35, Issue 4
April 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Antioxidants and Pro-oxidants on Cytotoxicity of Dihydroartemisinin to Molt-4 Human Leukemia Cells
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
16 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Effects of Antioxidants and Pro-oxidants on Cytotoxicity of Dihydroartemisinin to Molt-4 Human Leukemia Cells
THOMAS GERHARDT, ROSS JONES, JUNGSOO PARK, RUI LU, HO WING CHAN, QINGXI FANG, NARENDRA SINGH, HENRY LAI
Anticancer Research Apr 2015, 35 (4) 1867-1871;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Effects of Antioxidants and Pro-oxidants on Cytotoxicity of Dihydroartemisinin to Molt-4 Human Leukemia Cells
THOMAS GERHARDT, ROSS JONES, JUNGSOO PARK, RUI LU, HO WING CHAN, QINGXI FANG, NARENDRA SINGH, HENRY LAI
Anticancer Research Apr 2015, 35 (4) 1867-1871;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Docosahexaenoic Acid Potentiates the Anticancer Effect of the Menadione/Ascorbate Redox Couple by Increasing Mitochondrial Superoxide and Accelerating ATP Depletion
  • Streptonigrin Mitigates Lung Cancer-induced Cachexia by Suppressing TCF4/TWIST1-induced PTHLH Expression
  • Atezolizumab Retains Cellular Binding to Programmed Death Ligand 1 Following Aerosolization via Mesh Nebulizer
Show more Experimental Studies

Similar Articles

Keywords

  • Artemisinin
  • sodium ascorbate
  • vitamin D3
  • Trolox
  • dexamethasone
  • hydrogen peroxide
  • Molt-4 cells
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire